The ongoing conflict involving Iran is exerting pressure on Nigeria’s health sector, with reports indicating a sharp increase in drug prices by as much as 30 percent. Drug price surge refers to a significant increase in the cost of pharmaceutical products, often driven by supply disruptions and currency fluctuations.
Healthcare stakeholders attribute the rise to global supply chain disruptions and increased costs of importing medical supplies.
Observers note that Nigeria relies heavily on imported pharmaceuticals, making the sector vulnerable to international crises and exchange rate volatility.
Medical professionals have raised concerns about the impact on patient care, warning that higher drug prices could limit access to essential medications.
Stakeholders have urged the Federal Government of Nigeria to implement measures to stabilise the sector, including support for local drug manufacturing.
Experts emphasise the importance of strengthening domestic pharmaceutical production to reduce dependence on imports.
The development underscores the broader impact of global conflicts on local economies and public health systems.
Analysts believe that proactive policy interventions will be necessary to mitigate the effects on healthcare delivery.
